Trials / Unknown
UnknownNCT01088269
Blood Pressure Assessment in Atrial Fibrillation
Evaluation of the Oscillometric Blood Pressure Measurement in Atrial Fibrillation and Relation of Blood Pressure With Serum Biomarkers and Echocardiographic Indexes
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- University of Athens · Academic / Other
- Sex
- All
- Age
- 25 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This is a cross-sectional study including patients with permanent atrial fibrillation. Assessment will include: * clinic blood pressure measurements (mercury sphygmomanometer and automated oscillometric device) * 24-hour ambulatory blood pressure monitoring * determination of various serum markers and cardiac ultrasound. * evaluation of a 24h ambulatory blood pressure monitoring device (Microlife WatchBPO3) in terms of its diagnostic value for the detection of atrial fibrillation compared with the reference 24h Holter ECG
Conditions
Timeline
- Start date
- 2010-03-01
- Primary completion
- 2017-12-01
- Completion
- 2017-12-01
- First posted
- 2010-03-17
- Last updated
- 2017-09-14
Locations
1 site across 1 country: Greece
Source: ClinicalTrials.gov record NCT01088269. Inclusion in this directory is not an endorsement.